$29.39
0.270.93%
近くで: Apr 14, 5:00 PM EST
$29.97
0.852.92%
プレマーケット: 6:44 AM EST
Benzinga
Benzinga
Benzinga
木曜日, 4 16
Benzinga
© 2026 Benzinga | All Rights Reserved
最新の Roivant Sciences インサイダー取引活動を追跡します。Roivant Sciences 株の最近の購入、売却、市場への影響について最新情報を入手してください。
インサイダー取引とは、役員、取締役、従業員などの企業内部関係者が自社の株式の取引を行う行為です。インサイダーの売買取引は、会社の将来の業績に対する彼らの信頼を知る貴重な洞察を提供します。
Roivant Sciences Ltdでは、最近の内部関係者の活動が注目を集めています。過去 30 日間で、内部関係者は合計 55.40K 株相当の $1.58M 株を売却したと報告しています。過去 30 日間に購入がなかったと報告します。
| Apr 10, 2026 | Jennifer Humes | CHIEF ACCOUNTING OFFICER | -13.54K | $28.37 | -$384.07K | SELL | -13.85% | 84.19K | Apr 08 | View |
| Mar 30, 2026 | Meghan FitzGerald | — | 0.00 | $18.13 | -$1.31M | SELL-OPTIONS | 0.00% | 42.96K | Mar 26 | View |
| Mar 19, 2026 | Eric Venker | PRESIDENT & IMMUNOVANT CEO | 0.00 | $16.04 | -$4.88M | SELL-OPTIONS | 0.00% | 1.65M | Mar 17 | View |
| Mar 18, 2026 | Melissa B Epperly | DIRECTOR | -41.86K | $28.68 | -$1.20M | SELL | -72.59% | 15.80K | Mar 16 | View |
| Feb 23, 2026 | Frank Torti | PRESIDENT AND VANT CHAIR | 0.00 | $15.60 | -$70.49M | SELL-OPTIONS | 0.00% | 13.74M | Feb 19 - Feb 23 | View |
| Feb 18, 2026 | Eric Venker | PRESIDENT & IMMUNOVANT CEO | 0.00 | $15.17 | -$4.53M | SELL-OPTIONS | 0.00% | 1.65M | Feb 13 | View |
| Feb 13, 2026 | Keith Manchester | — | -1.23M | $26.64 | -$32.66M | SELL | -7.50% | 15.13M | Feb 11 - Feb 13 | View |
| Feb 13, 2026 | Dan Gold | — | -1.23M | $26.64 | -$32.66M | SELL | -7.50% | 15.13M | Feb 11 - Feb 13 | View |
| Feb 13, 2026 | QVT Financial LP | — | -1.23M | $26.64 | -$32.66M | SELL | -7.50% | 15.13M | Feb 11 - Feb 13 | View |
| Feb 11, 2026 | Mayukh Sukhatme | PRESIDENT & CIO | 0.00 | $19.57 | -$8.98M | SELL-OPTIONS | 0.00% | 18.84M | Feb 09 | View |
| Jan 14, 2026 | Eric Venker | PRESIDENT & IMMUNOVANT CEO | 0.00 | $12.89 | -$3.61M | SELL-OPTIONS | 0.00% | 1.65M | Jan 12 | View |
| Dec 31, 2025 | Mayukh Sukhatme | PRESIDENT & CIO | 0.00 | $17.20 | -$28.90M | SELL-OPTIONS | 0.00% | 18.84M | Dec 29 - Dec 31 | View |
| Dec 29, 2025 | Richard Pulik | CFO | -146.73K | $13.14 | -$8.12M | SELL | -38.00% | 239.41K | Dec 23 | View |
| Dec 29, 2025 | Eric Venker | PRESIDENT & IMMUNOVANT CEO | 156.69K | $13.16 | -$4.52M | SELL-OPTIONS | 10.46% | 1.65M | Dec 23 - Dec 24 | View |
| Dec 19, 2025 | Mayukh Sukhatme | PRESIDENT & CIO | 0.00 | $17.88 | -$619.53K | SELL-OPTIONS | 0.00% | 18.84M | Dec 17 | View |
| Dec 18, 2025 | Dan Gold | — | -1.69M | $23.05 | -$39.07M | SELL | -9.39% | 16.35M | Dec 16 - Dec 17 | View |
| Dec 18, 2025 | Keith Manchester | — | -1.69M | $23.05 | -$39.07M | SELL | -9.39% | 16.35M | Dec 16 - Dec 17 | View |
| Dec 18, 2025 | QVT Financial LP | — | -1.69M | $23.05 | -$39.07M | SELL | -9.39% | 16.35M | Dec 16 - Dec 17 | View |
| Dec 17, 2025 | Matthew Gline | CEO | 0.00 | $16.92 | -$36.85M | SELL-OPTIONS | 0.00% | 17.29M | Dec 15 | View |
| Dec 15, 2025 | Vivek Ramaswamy | 10% OWNER | -1.00 | $17.28 | -$67.92M | SELL | -0.00% | 47.01M | Dec 11 - Dec 15 | View |
| Dec 11, 2025 | Eric Venker | PRESIDENT & IMMUNOVANT CEO | 0.00 | $12.35 | -$3.40M | SELL-OPTIONS | 0.00% | 1.50M | Dec 09 | View |
| Nov 21, 2025 | Keith Manchester | — | -1.30M | $20.23 | -$26.30M | SELL | -6.72% | 18.05M | Nov 19 | View |
| Nov 21, 2025 | Dan Gold | — | -1.30M | $20.23 | -$26.30M | SELL | -6.72% | 18.05M | Nov 19 | View |
| Nov 21, 2025 | QVT Financial LP | — | -1.30M | $20.23 | -$26.30M | SELL | -6.72% | 18.05M | Nov 19 | View |
| Nov 17, 2025 | Vivek Ramaswamy | 10% OWNER | -1.85M | $20.46 | -$37.94M | SELL | -3.80% | 47.01M | Nov 13 - Nov 17 | View |
| Nov 07, 2025 | Eric Venker | PRESIDENT & IMMUNOVANT CEO | 0.00 | $12.04 | -$3.27M | SELL-OPTIONS | 0.00% | 1.50M | Nov 07 | View |
| Oct 17, 2025 | Eric Venker | PRESIDENT & IMMUNOVANT CEO | 0.00 | $16.42 | -$973.08K | SELL-OPTIONS | 0.00% | 1.50M | Oct 15 - Oct 17 | View |
| Oct 14, 2025 | Eric Venker | PRESIDENT & IMMUNOVANT CEO | 0.00 | $16.07 | -$55.51K | SELL-OPTIONS | 0.00% | 1.50M | Oct 09 - Oct 13 | View |
| Oct 08, 2025 | Eric Venker | PRESIDENT & IMMUNOVANT CEO | 0.00 | $12.58 | -$4.83M | SELL-OPTIONS | 0.00% | 1.50M | Oct 06 - Oct 08 | View |
| Sep 23, 2025 | Eric Venker | PRESIDENT & IMMUNOVANT CEO | -148.63K | $9.38 | -$19.51M | SELL | -8.99% | 1.50M | Sep 19 - Sep 23 | View |
| Sep 18, 2025 | Matthew Gline | CEO | 3.31K | $15.07 | $49.96K | BUY | 0.02% | 17.29M | Sep 18 | View |
| Sep 05, 2025 | Vivek Ramaswamy | 10% OWNER | -1.78M | $12.65 | -$22.46M | SELL | -3.51% | 48.87M | Sep 03 - Sep 05 | View |
| Aug 22, 2025 | Eric Venker | PRESIDENT & IMMUNOVANT CEO | -7.05K | $7.78 | -$869.64K | SELL | -0.42% | 1.65M | Aug 20 | View |
| Jul 23, 2025 | Eric Venker | PRESIDENT & IMMUNOVANT CEO | 0.00 | $7.68 | -$767.00K | SELL-OPTIONS | 0.00% | 1.46M | Jul 21 | View |
| Jun 24, 2025 | Eric Venker | PRESIDENT & COO | 0.00 | $7.65 | -$760.00K | SELL-OPTIONS | 0.00% | 1.46M | Jun 20 | View |
| Jun 23, 2025 | Vivek Ramaswamy | 10% OWNER | -1.14M | $11.46 | -$13.08M | SELL | -2.21% | 50.64M | Jun 18 - Jun 20 | View |
| Jun 06, 2025 | Vivek Ramaswamy | 10% OWNER | -748.23K | $11.30 | -$8.45M | SELL | -1.42% | 51.78M | Jun 04 - Jun 06 | View |
| Jun 04, 2025 | Eric Venker | PRESIDENT & COO | 385.03K | $7.50 | -$5.82M | SELL-OPTIONS | 35.74% | 1.46M | Jun 02 - Jun 03 | View |
| May 22, 2025 | Eric Venker | PRESIDENT & COO | -39.15K | $7.41 | -$1.14M | SELL | -3.51% | 1.08M | May 20 | View |
| May 08, 2025 | Vivek Ramaswamy | — | -898.96K | $11.27 | -$10.13M | SELL | -1.68% | 52.53M | May 06 - May 07 | View |
| Apr 22, 2025 | Eric Venker | PRESIDENT & COO | -10.95K | $7.03 | -$748.09K | SELL | -0.97% | 1.12M | Apr 20 - Apr 21 | View |
| Mar 24, 2025 | Eric Venker | PRESIDENT & COO | 241.37K | $7.39 | -$4.45M | SELL-OPTIONS | 27.24% | 1.13M | Mar 20 - Mar 24 | View |
| Feb 24, 2025 | Eric Venker | PRESIDENT & COO | -10.95K | $7.25 | -$797.33K | SELL | -1.22% | 885.92K | Feb 20 | View |
| Feb 18, 2025 | Rakhi Kumar | CHIEF ACCOUNTING OFFICER | -40.00K | $7.14 | -$1.65M | SELL | -19.68% | 163.26K | Feb 13 | View |
| Feb 14, 2025 | Eric Venker | PRESIDENT & COO | 164.57K | $7.16 | -$2.25M | SELL-OPTIONS | 22.47% | 896.87K | Feb 12 - Feb 13 | View |
| Jan 22, 2025 | Eric Venker | PRESIDENT & COO | -8.68K | $7.56 | -$839.80K | SELL | -1.17% | 732.29K | Jan 20 - Jan 21 | View |
| Dec 31, 2024 | Eric Venker | PRESIDENT & COO | 145.40K | $7.76 | -$2.22M | SELL-OPTIONS | 24.41% | 740.98K | Dec 27 - Dec 30 | View |
| Dec 26, 2024 | Mayukh Sukhatme | PRES&CHIEF INVESTMENT OFFICER | 0.00 | $7.93 | -$7.23M | SELL-OPTIONS | 0.00% | 18.84M | Dec 23 - Dec 26 | View |
| Dec 26, 2024 | Eric Venker | PRESIDENT & COO | -10.95K | $7.67 | -$890.63K | SELL | -1.80% | 595.58K | Dec 20 | View |
| Dec 20, 2024 | Mayukh Sukhatme | PRES&CHIEF INVESTMENT OFFICER | 0.00 | $7.95 | -$3.38M | SELL-OPTIONS | 0.00% | 18.84M | Dec 18 | View |
| Nov 22, 2024 | Eric Venker | PRESIDENT & COO | -10.95K | $7.59 | -$872.76K | SELL | -1.77% | 606.52K | Nov 20 | View |
| Oct 22, 2024 | Eric Venker | PRESIDENT & COO | -10.95K | $7.76 | -$910.46K | SELL | -1.74% | 617.47K | Oct 20 - Oct 21 | View |
| Sep 26, 2024 | QVT Financial LP | — | -926.00K | $11.82 | -$10.94M | SELL | -3.58% | 24.94M | Sep 25 - Sep 26 | View |
| Sep 26, 2024 | Keith Manchester | — | -503.00K | $11.66 | -$5.87M | SELL | -28.26% | 1.28M | Sep 24 - Sep 25 | View |
| Sep 26, 2024 | Dan Gold | — | -4.43M | $11.71 | -$51.82M | SELL | -16.64% | 22.18M | Sep 24 - Sep 26 | View |
| Sep 24, 2024 | Matthew Gline | CEO | -942.74K | $7.84 | -$23.51M | SELL | -5.15% | 17.37M | Sep 20 - Sep 23 | View |
| Sep 24, 2024 | Rakhi Kumar | CHIEF ACCOUNTING OFFICER | -3.09K | $7.87 | -$2.05M | SELL | -1.45% | 209.32K | Sep 20 - Sep 23 | View |
| Feb 09, 2024 | Eric Venker | PRESIDENT & COO | 0.00 | $7.38 | -$685.44K | SELL-OPTIONS | 0.00% | 532.21K | Feb 09 | View |
| Jan 03, 2024 | Vivek Ramaswamy | 10% OWNER | -3.00M | $11.05 | -$33.15M | SELL | -5.46% | 51.93M | Jan 02 | View |
| Oct 04, 2023 | Eric Venker | CHIEF OPERATING OFFICER | 0.00 | $7.14 | -$7.90M | SELL-OPTIONS | 0.00% | 595.40K | Oct 02 - Oct 05 | View |
| Oct 02, 2023 | Keith Manchester | — | -6.90M | $11.55 | -$79.65M | SELL | -57.85% | 5.02M | Sep 28 | View |
| Oct 02, 2023 | SVF Investments UK LtdSVF Holdings UK LLPSoftBank Vision Fund LPSB INVESTMENT ADVISERS UK LTD | — | -10.00M | $12.60 | -$126.00M | SELL | -12.04% | 73.03M | Sep 28 | View |
| Oct 02, 2023 | Allen Daniel Gold | DIRECTOR | -10.00M | $11.55 | -$115.50M | SELL | -66.56% | 5.02M | Sep 28 | View |
| Oct 02, 2023 | QVT Financial LP | — | -10.00M | $11.55 | -$115.50M | SELL | -66.56% | 5.02M | Sep 28 | View |
| Sep 29, 2023 | Eric Venker | PRESIDENT & COO | 0.00 | $8.44 | -$4.58M | SELL-OPTIONS | 0.00% | 595.40K | Sep 27 | View |
| Sep 12, 2023 | Eric Venker | CHIEF OPERATING OFFICER | 0.00 | $8.02 | -$887.63K | SELL-OPTIONS | 0.00% | 611.81K | Sep 08 | View |
| Sep 12, 2023 | Rakhi Kumar | CHIEF ACCOUNTING OFFICER | 0.00 | $9.33 | -$566.29K | SELL-OPTIONS | 0.00% | 197.95K | Sep 08 | View |
| Sep 07, 2023 | Rakhi Kumar | CHIEF ACCOUNTING OFFICER | 0.00 | $9.24 | -$9.52K | SELL-OPTIONS | 0.00% | 197.95K | Sep 05 | View |
| Sep 06, 2023 | Eric Venker | CHIEF OPERATING OFFICER | 0.00 | $7.88 | -$757.58K | SELL-OPTIONS | 0.00% | 611.81K | Sep 01 - Sep 06 | View |
| Aug 16, 2023 | Eric Venker | CHIEF OPERATING OFFICER | 0.00 | $7.87 | -$480.88K | SELL-OPTIONS | 0.00% | 627.92K | Aug 14 | View |
| Aug 07, 2023 | Eric Venker | CHIEF OPERATING OFFICER | 0.00 | $7.89 | -$360.60K | SELL-OPTIONS | 0.00% | 627.92K | Aug 03 | View |
| Aug 03, 2023 | Rakhi Kumar | CHIEF ACCOUNTING OFFICER | 0.00 | $9.24 | -$22.17K | SELL-OPTIONS | 0.00% | 199.33K | Aug 01 - Aug 03 | View |
| Aug 02, 2023 | Eric Venker | CHIEF OPERATING OFFICER | 0.00 | $7.88 | -$1.57M | SELL-OPTIONS | 0.00% | 627.92K | Jul 31 - Aug 02 | View |
| Jul 27, 2023 | Eric Venker | CHIEF OPERATING OFFICER | 0.00 | $7.38 | -$886.51K | SELL-OPTIONS | 0.00% | 627.92K | Jul 25 - Jul 27 | View |
| Jul 24, 2023 | Eric Venker | PRESIDENT & COO | -16.30K | $7.52 | -$2.93M | SELL | -2.53% | 627.92K | Jul 20 - Jul 24 | View |
| Jul 18, 2023 | Rakhi Kumar | CHIEF ACCOUNTING OFFICER | 0.00 | $9.24 | -$3.51K | SELL-OPTIONS | 0.00% | 82.13K | Jul 14 - Jul 18 | View |
| Jun 26, 2023 | VIKING GLOBAL INVESTORS LPDavid OttANDREAS OLE HALVORSENSharon Rose ShabetViking Global Opportunities Illiquid Investments SubMaster LPViking Global Opportunities GP LLCViking Global Opportunities Portfolio GP LLCViking Global Opportunities Parent GP LLC | — | -13.00M | $9.90 | -$128.70M | SELL | -50.22% | 12.88M | Jun 22 | View |
| Jun 26, 2023 | VIKING GLOBAL PERFORMANCE LLCDavid OttANDREAS OLE HALVORSENSharon Rose ShabetViking Global Equities Master LtdViking Global Equities II LPViking Long Fund Master LtdViking Long Fund GP LLC | — | -13.00M | $9.90 | -$128.70M | SELL | -50.22% | 12.88M | Jun 22 | View |
| Jun 26, 2023 | Sumitomo Chemical Co LtdSumitomo Pharma Co Ltd | 10% OWNER | -15.12M | $8.60 | -$130.00M | SELL | -17.50% | 71.25M | Jun 22 | View |
| Jun 13, 2023 | Rakhi Kumar | CHIEF ACCOUNTING OFFICER | 0.00 | $7.53 | -$211.13K | SELL-OPTIONS | 0.00% | 198.58K | Jun 09 | View |
| Jun 09, 2023 | Eric Venker | PRESIDENT & COO | 0.00 | $6.88 | -$1.82M | SELL-OPTIONS | 0.00% | 660.10K | Jun 07 - Jun 09 | View |
| May 25, 2023 | Eric Venker | PRESIDENT & COO | -15.67K | $6.72 | -$152.62K | SELL | -2.32% | 660.10K | May 23 | View |
| May 11, 2023 | Eric Venker | PRESIDENT & COO | 0.00 | $6.54 | -$1.28M | SELL-OPTIONS | 0.00% | 675.77K | May 09 | View |
| May 08, 2023 | Eric Venker | PRESIDENT & COO | 0.00 | $6.20 | -$706.26K | SELL-OPTIONS | 0.00% | 675.77K | May 04 - May 08 | View |
| May 03, 2023 | Eric Venker | PRESIDENT & COO | 0.00 | $6.12 | -$1.31M | SELL-OPTIONS | 0.00% | 675.77K | May 01 - May 03 | View |
| May 03, 2023 | Rakhi Kumar | CHIEF ACCOUNTING OFFICER | 0.00 | $6.20 | -$365.21K | SELL-OPTIONS | 0.00% | 200.14K | May 01 - May 02 | View |
| Apr 28, 2023 | Rakhi Kumar | CHIEF ACCOUNTING OFFICER | 0.00 | $6.22 | -$1.08M | SELL-OPTIONS | 0.00% | 200.14K | Apr 26 - Apr 28 | View |
| Apr 28, 2023 | Eric Venker | PRESIDENT & COO | 0.00 | $6.20 | -$1.04M | SELL-OPTIONS | 0.00% | 675.77K | Apr 26 - Apr 28 | View |
| Mar 22, 2023 | SVF Investments UK LtdSoftBank Vision Fund LPSVF Holdings UK LLPSB INVESTMENT ADVISERS UK LTD | 10% OWNER | -12.00M | $8.00 | -$96.00M | SELL | -12.63% | 83.03M | Mar 20 | View |
| Mar 03, 2023 | Richard Pulik | CFO | -1.91K | $8.08 | -$15.45K | SELL | -0.85% | 223.35K | Mar 01 | View |
| Feb 22, 2023 | Vivek Ramaswamy | — | -4.00M | $7.95 | -$31.80M | SELL | -6.85% | 54.41M | Feb 22 | View |
| Jan 06, 2023 | Eric Venker | PRESIDENT & COO | -24.04K | $8.02 | -$192.78K | SELL | -3.19% | 729.43K | Jan 05 | View |
| Jan 04, 2023 | Eric Venker | PRESIDENT & COO | -119.25K | $7.46 | -$889.03K | SELL | -13.66% | 753.47K | Dec 30 - Jan 03 | View |
| Dec 09, 2022 | Eric Venker | PRESIDENT & COO | -145.10K | $7.03 | -$1.02M | SELL | -14.04% | 888.74K | Dec 08 - Dec 09 | View |
| Nov 15, 2022 | SVF Investments UK LtdSoftBank Vision Fund LPSVF Holdings UK LLPSB INVESTMENT ADVISERS UK LTD | 10% OWNER | -4.34M | $4.75 | -$20.63M | SELL | -4.37% | 95.03M | Nov 10 | View |
| Nov 14, 2022 | QVT Financial LP | DIRECTOR | -6.85M | $4.75 | -$26.87M | SELL | -55.61% | 5.47M | Nov 09 - Nov 10 | View |
| Nov 14, 2022 | Daniel Gold | DIRECTOR | -7.60M | $4.75 | -$26.87M | SELL | -58.15% | 5.47M | Nov 09 - Nov 10 | View |
| Nov 14, 2022 | Keith Manchester | DIRECTOR | -5.12M | $4.75 | -$18.63M | SELL | -48.34% | 5.47M | Nov 09 - Nov 10 | View |
| Nov 14, 2022 | Dexcel Pharma Technologies LtdDexxon Holdings LtdDan Oren | 10% OWNER | 4.00M | $5.00 | $20.00M | BUY | 4.05% | 102.85M | Nov 10 | View |
| Oct 27, 2022 | Matthew Gline | CEO | -19.28K | $4.40 | -$84.81K | SELL | -1.63% | 1.16M | Oct 25 | View |
| Oct 27, 2022 | Rakhi Kumar | CHIEF ACCOUNTING OFFICER | -1.59K | $4.40 | -$6.99K | SELL | -1.13% | 139.35K | Oct 25 | View |
| Oct 27, 2022 | Eric Venker | PRESIDENT & COO | -15.92K | $4.40 | -$70.06K | SELL | -1.49% | 1.05M | Oct 25 | View |
| Sep 27, 2022 | Rakhi Kumar | CHIEF ACCOUNTING OFFICER | -1.74K | $3.07 | -$5.34K | SELL | -1.22% | 140.94K | Sep 23 | View |
| Sep 27, 2022 | Eric Venker | PRESIDENT & COO | -17.39K | $3.07 | -$53.39K | SELL | -1.61% | 1.07M | Sep 23 | View |
| Sep 27, 2022 | Matthew Gline | CEO | -21.05K | $3.07 | -$64.63K | SELL | -1.75% | 1.18M | Sep 23 | View |
| Aug 26, 2022 | Rakhi Kumar | CHIEF ACCOUNTING OFFICER | -1.65K | $3.71 | -$6.13K | SELL | -1.14% | 142.68K | Aug 24 | View |
| Aug 26, 2022 | Eric Venker | PRESIDENT & COO | -16.53K | $3.71 | -$61.33K | SELL | -1.50% | 1.08M | Aug 24 | View |
| Aug 26, 2022 | Matthew Gline | CEO | -20.01K | $3.71 | -$74.23K | SELL | -1.63% | 1.20M | Aug 24 | View |
| Jul 27, 2022 | Matthew Gline | CEO | -20.45K | $4.33 | -$88.57K | SELL | -1.64% | 1.22M | Jul 25 | View |
| Jul 27, 2022 | Rakhi Kumar | CHIEF ACCOUNTING OFFICER | -1.69K | $4.33 | -$7.30K | SELL | -1.15% | 144.34K | Jul 25 | View |
| Jul 27, 2022 | Eric Venker | PRESIDENT & COO | -16.90K | $4.33 | -$73.16K | SELL | -1.51% | 1.10M | Jul 25 | View |
| Jun 27, 2022 | Rakhi Kumar | CHIEF ACCOUNTING OFFICER | -1.64K | $4.34 | -$7.10K | SELL | -1.11% | 146.02K | Jun 23 | View |
| Jun 27, 2022 | Matthew Gline | CEO | -19.86K | $4.34 | -$86.17K | SELL | -1.57% | 1.24M | Jun 23 | View |
| Jun 27, 2022 | Eric Venker | PRESIDENT & COO | -16.40K | $4.34 | -$71.18K | SELL | -1.45% | 1.12M | Jun 23 | View |
| May 24, 2022 | Matthew Gline | CEO | -139.79K | $3.70 | -$517.23K | SELL | -9.95% | 1.26M | May 20 | View |
| May 24, 2022 | Eric Venker | PRESIDENT & COO | -136.42K | $3.70 | -$504.76K | SELL | -10.75% | 1.13M | May 20 | View |
| May 24, 2022 | Rakhi Kumar | CHIEF ACCOUNTING OFFICER | -12.13K | $3.70 | -$44.87K | SELL | -7.59% | 147.66K | May 20 | View |
| Apr 27, 2022 | Rakhi Kumar | CHIEF ACCOUNTING OFFICER | -703.00 | $3.84 | -$2.70K | SELL | -0.44% | 159.78K | Apr 25 | View |
| Apr 27, 2022 | Eric Venker | PRESIDENT & COO | -5.11K | $3.84 | -$19.61K | SELL | -0.40% | 1.27M | Apr 25 | View |
| Apr 27, 2022 | Matthew Gline | CEO | -8.51K | $3.84 | -$32.67K | SELL | -0.60% | 1.40M | Apr 25 | View |
| Apr 26, 2022 | Dexcel Pharma Technologies LtdDexxon Holdings LtdDan Oren | 10% OWNER | 40.28K | $3.85 | $154.95K | BUY | 0.04% | 98.85M | Apr 22 - Apr 25 | View |
| Apr 01, 2022 | Eric Venker | PRESIDENT & COO | -34.43K | $4.80 | -$165.12K | SELL | -2.63% | 1.27M | Mar 30 | View |
| Apr 01, 2022 | Rakhi Kumar | CHIEF ACCOUNTING OFFICER | -4.56K | $4.79 | -$21.88K | SELL | -2.76% | 160.49K | Mar 30 | View |
| Apr 01, 2022 | Matthew Gline | CEO | -58.94K | $4.80 | -$282.74K | SELL | -4.00% | 1.41M | Mar 30 | View |
| Mar 29, 2022 | Eric Venker | PRESIDENT & COO | -80.05K | $5.06 | -$405.03K | SELL | -5.76% | 1.31M | Mar 25 | View |
| Mar 29, 2022 | Matthew Gline | CEO | -35.39K | $5.06 | -$179.05K | SELL | -2.35% | 1.47M | Mar 25 | View |
| Mar 29, 2022 | Rakhi Kumar | CHIEF ACCOUNTING OFFICER | -7.28K | $5.06 | -$36.84K | SELL | -4.23% | 165.05K | Mar 25 | View |
| Mar 22, 2022 | Rakhi Kumar | CHIEF ACCOUNTING OFFICER | -2.15K | $5.13 | -$11.04K | SELL | -1.23% | 172.33K | Mar 18 | View |
| Mar 22, 2022 | Matthew Gline | CEO | -82.01K | $5.13 | -$420.69K | SELL | -5.16% | 1.51M | Mar 18 | View |
| Mar 09, 2022 | Rakhi Kumar | CHIEF ACCOUNTING OFFICER | -3.09K | $5.52 | -$17.06K | SELL | -1.74% | 174.48K | Mar 07 | View |
| Mar 09, 2022 | Matthew Gline | CEO | -92.32K | $5.52 | -$509.63K | SELL | -5.49% | 1.59M | Mar 07 | View |